Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMICROBIOMA in Clostridioides Difficile Infection
NCT06107569Phase 3Not yet recruiting
- Sponsor
- Hospital Universitário Evangélico Mackenzie
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of Promicrobioma in Clostridioides difficile infection (CDI), sponsored by Hospital Universitário Evangélico Mackenzie. Planned start May 2024; status: not yet recruiting.
02
Drugs
Promicrobioma
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT06107569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06107569.